Sarepta Elevidys $1B Annual Sales by 2025? | Binary | | | 6 months ago | |
Sarepta Stock $200 by 2024? | Binary | | | 6 months ago | |
Sarepta Elevidys Full FDA Approval for Non-Amb Patients by June 2025? | Binary | | | 6 months ago | |
Sarepta Stock Price at End of Q4 2024 | Categorical | | | 6 months ago | |
Sarepta stock price exceeds $200 by end of Q1 2025? | Categorical | | | 6 months ago | |
ELEVIDYS receives EU approval by end of 2024? | Categorical | | | 6 months ago | |
ELEVIDYS $500 million sales by end of 2024? | Binary | | | 6 months ago | |
ELEVIDYS further label expansion by mid-2025? | Binary | | | 6 months ago | |
ELEVIDYS full approval for non-ambulatory patients by end of 2024? | Binary | | | 6 months ago | |
ELEVIDYS best-selling gene therapy in US by end of 2024? | Categorical | | | 6 months ago | |
Outcome of Pfizer's next DMD gene therapy trial by end of 2025? | Categorical | | | 6 months ago | |
FDA to approve any DMD gene therapy by mid-2025? | Binary | | | 6 months ago | |
Which company will announce the next major DMD treatment development by end of 2024? | Categorical | | | 6 months ago | |
Sarepta Total US Sales from Elevidys by 2025 | Categorical | | | 6 months ago | |
Total DMD Patients Treated with Elevidys by 2024 | Categorical | | | 6 months ago | |
Pfizer stock price to recover to pre-trial announcement levels by end of 2024? | Binary | | | 6 months ago | |
Pfizer to announce new DMD gene therapy trial by end of 2024? | Binary | | | 6 months ago | |
Which company will see the highest stock increase by end of 2024? | Categorical | | | 6 months ago | |
